Search results for "Prosthesis"

showing 10 items of 719 documents

Trans-popliteal hybrid retrograde technique for revascularization of chronic total occlusions of the superficial femoral artery.

2020

Objectives We present the technical description and preliminary results of a hybrid approach for the treatment of chronic total occlusions of superficial femoral artery in the setting of critical limb-threatening ischemia (CLTI). Methods A retrospective analysis of selected case series was performed. A trans-popliteal hybrid technique was carried out in seven limbs (six patients). Open exposure of above-the-knee popliteal artery was performed over its maximum calcification zone. After retrograde recanalization and graft-stenting of the entire superficial femoral artery, endarterectomy of the popliteal artery was performed for debulking and widening of the distal landing zone of the endopros…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCritical IllnessConstriction PathologicEndarterectomy030204 cardiovascular system & hematologyRevascularization030218 nuclear medicine & medical imaging03 medical and health sciencesBlood Vessel Prosthesis ImplantationPeripheral Arterial Disease0302 clinical medicineIschemiamedicineHumansRadiology Nuclear Medicine and imagingPopliteal ArteryVascular PatencyAgedRetrospective Studiesbusiness.industrySuperficial femoral arteryEndovascular ProceduresGeneral MedicineCritical limb ischemiaMiddle Agedmedicine.diseaseHybrid approachBlood Vessel ProsthesisFemoral ArteryTreatment OutcomeChronic DiseaseRetrograde approachSurgeryFemaleStentsRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationVascular
researchProduct

Patency of renal and visceral vessels after open thoracoabdominal aortic replacement.

2015

Objective In thoracoabdominal aortic aneurysms (TAAAs), a paradigm shift is observed from open surgery toward total endovascular aortic repair using fenestrated and branched endografts. Whereas outcome after open replacement in terms of mortality and paraplegia has been evaluated extensively, no studies exist addressing long-term patency of visceral and renal vessels. To enable comparison of target vessel patency between open and endovascular treatment, we analyzed our series of open TAAA replacements. Methods Our vascular surgery database was screened for patients who received open TAAA replacement between 1998 and 2012, and patient records were analyzed retrospectively. All available imag…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentKaplan-Meier EstimateRevascularizationAortographyMagnetic resonance angiographyAortic aneurysmBlood Vessel Prosthesis ImplantationRenal ArteryRisk Factorsmedicine.arterymedicineVascular PatencyHumansSuperior mesenteric arteryRenal arteryVascular PatencyAgedRetrospective Studiesmedicine.diagnostic_testAortic Aneurysm Thoracicbusiness.industryGraft Occlusion VascularVascular surgeryMiddle Agedmedicine.diseaseSurgeryVisceraTreatment OutcomeCardiothoracic surgerycardiovascular systemSurgeryFemaleRadiologyCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedMagnetic Resonance AngiographyJournal of vascular surgery
researchProduct

Long-Term Results of Stenting of the Aortic Bifurcation

2012

Background To evaluate the long-term results in a multicentric continuous series of narrowing lesions of the aortic bifurcation treated with a kissing stent. Methods From January, 1st 1999 to the December, 31st 2001, all of the patients ( n = 80) presenting with stenosis of the aortic bifurcation ( n = 15) and/or the 2 common iliac arteries ( n = 65), treated with a kissing stent, in 8 teaching hospitals were collected retrospectively. The risk factors were smoking (91%), dyslipidemia (60%), arterial hypertension (42%) and diabetes (27%). In 84% of cases, the indication for treatment was claudication. The lesions were stenotic n = 76) and/or thrombotic ( n = 18). The associated lesions were…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationArterial Occlusive DiseasesDissection (medical)Iliac ArterySeverity of Illness IndexDiagnosis DifferentialBlood Vessel Prosthesis Implantationmedicine.arteryAngioplastymedicineHumansAorta AbdominaleducationRetrospective StudiesAortaeducation.field_of_studybusiness.industryStentGeneral MedicineAortic bifurcationMiddle Agedmedicine.diseaseSurgeryFemoral ArteryStenosisTreatment Outcomemedicine.anatomical_structureFemaleStentsSurgeryRadiologymedicine.symptomTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessClaudicationMagnetic Resonance AngiographyFollow-Up StudiesAnnals of Vascular Surgery
researchProduct

Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Elutin…

2009

Objectives: We sought to evaluate the safety and performance of the Janus Tacrolimus-Eluting stent (TES) in an unselected population of patients, without application of restrictive clinical or angiographic criteria. Background: Continued attention to the safety, efficacy, and deliverability of first-generation drug eluting stents has led to the development of new antiproliferative agents with alternative stent platforms and different drug carrier vehicles. Methods: The TEST (Tacrolimus Eluting STent) registry is a prospective, nonrandomized single-center registry in which 140 consecutive patients who underwent single- or multi-vessel percutaneous coronary intervention between February 2005 …

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationMyocardial InfarctionRestenosiKaplan-Meier EstimateCoronary AngiographyProsthesis DesignRisk AssessmentTacrolimusCoronary RestenosisRestenosismedicineHumansRadiology Nuclear Medicine and imagingMyocardial infarctionProspective StudiesRegistriesAngioplasty Balloon CoronaryeducationAgededucation.field_of_studybusiness.industryCoronary StenosisStentPercutaneous coronary interventionTacrolimus eluting stent.Cardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseTacrolimusSurgeryTreatment OutcomeAntiproliferative AgentsFemaleRadiologySafetyCardiology and Cardiovascular MedicinebusinessMaceCatheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions
researchProduct

Feasibility of Implanting 50-60 mm-Tapered Drug Eluting Stents in Chronic Total Occlusions.

2018

Abstract Background Percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) usually involves multiple overlapping stents implantation to cover long coronary segments. A higher rate of restenosis has been described with stent overlapping. Recently, new long tapered stents emerged as a potential tool for treating long coronary lesions. Feasibility of using these new devices for the CTO PCI has not been described. The aim of this work was to describe our initial experience with 50 and 60 mm-long tapered sirolimus-eluting stents (SES) in CTO PCI. Methods We included 54 consecutive patients who underwent a CTO PCI and in whom an attempt to implant a 50 or 60 mm-long tapered SE…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentTarget vessel030204 cardiovascular system & hematologyProsthesis DesignCoronary Restenosis03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRestenosismedicineHumanscardiovascular diseases030212 general & internal medicineVascular PatencyAgedRetrospective StudiesSirolimusbusiness.industryPercutaneous coronary interventionStentCardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSurgerysurgical procedures operativeTreatment OutcomeCoronary OcclusionConventional PCIChronic DiseaseFeasibility StudiesFemaleImplantCardiology and Cardiovascular MedicinebusinessCardiovascular revascularization medicine : including molecular interventions
researchProduct

Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year fo…

2017

Objectives to compare the 1-year outcome between bioresorbable vascular scaffold (BVS), everolimus-eluting stent (EES), and drug-eluting balloon (DEB) for in-stent restenosis (ISR) treatment. Background BVS has been proposed as alternative for ISR treatment. To date a direct comparison between BVS and DES or DEB for ISR treatment is lacking. Methods We retrospectively analyzed all ISR lesions treated with BVS, DEB, and EES from January 2012 to December 2014. A total of 548 lesions (498 patients) were included. By applying two propensity-score matching, 93 lesions treated with BVS were compared with 93 lesions treated with DEB, and 100 lesions treated with BVS were compared to 100 lesions tr…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentUrology030204 cardiovascular system & hematologyProsthesis DesignBalloonRisk AssessmentCardiac CathetersCoronary Restenosis03 medical and health sciences0302 clinical medicineCoated Materials BiocompatibleRestenosisRisk FactorsAbsorbable ImplantsmedicineHumansRadiology Nuclear Medicine and imagingEverolimus030212 general & internal medicineAngioplasty Balloon CoronaryPropensity ScoreAgedRetrospective StudiesBioresorbable vascular scaffoldin stent restenosibusiness.industryIncidence (epidemiology)percutaneous coronary interventionStentPercutaneous coronary interventionCardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseTreatment OutcomeItalyDrug-eluting stentPropensity score matchingFemalebioresorbable vascular scaffolddrug eluting balloonCardiology and Cardiovascular Medicinebusinessdrug eluting stent
researchProduct

Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).

2007

Objective Femoropopliteal bypass still is the standard surgical therapy for disabling claudication and critical ischemia. When autologous vein is not suitable synthetic or biological prostheses may be considered. Second generation glutaraldehyde tanned human umbilical vein (HUV) graft was chosen for above and below knee femoropopliteal bypass when autologous vein was not available. A single center experience regarding long-term graft function, secondary reinterventions, and potential biodegeneration of the HUV is presented. Methods Between January 1994 and January 2005, 211 consecutive femoropopliteal bypass operations with HUV (65 above knee and 146 below knee) were performed in 197 patien…

Malemedicine.medical_specialtyUmbilical VeinsTime FactorsTissue FixationAnastomosisProsthesis DesignSeverity of Illness IndexBlood Vessel Prosthesis ImplantationFixativesAneurysmIschemiamedicineHumansPopliteal ArteryDerivationVeinVascular PatencyAgedRetrospective StudiesUltrasonographyAged 80 and overBioprosthesismedicine.diagnostic_testbusiness.industryGreat saphenous veinGraft Occlusion VascularThrombosisIntermittent ClaudicationMiddle Agedmedicine.diseaseLimb SalvageThrombosisSurgeryBlood Vessel ProsthesisFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremityGlutaralAngiographySurgeryFemaleRadiologymedicine.symptombusinessClaudicationCardiology and Cardiovascular MedicineFollow-Up StudiesJournal of vascular surgery
researchProduct

Treatment of Severe Post-Prostatectomy Stress Urinary Incontinence Using Advance Sling

2010

Severe stress urinary incontinence (SUI) is usually treated by the implant of artificial sphincter positioned around bulbar urethra. AdVance sling is a functional, non-obstructive, anti-incontinence device that showed good results especially for mild and moderate SUI. We present our experience with AdVance sling in 7 patients with severe SUI unfit for artificial sphincter. Our results, after a follow-up of more than 6 months, showed a continence rate of 28% and an improvement rate of 43%, while 2 patients did not show any benefit. The success of AdVance sling depends on the integrity of urethral sphincter and can be applied also in selected cases for the treatment of severe post-prostatect…

Malemedicine.medical_specialtyUrinary Incontinence Stressmedicine.medical_treatmentUrologyUrinary incontinenceAdenocarcinomaDiabetes ComplicationsProsthesis ImplantationPostoperative ComplicationsHumansMedicinePost prostatectomyAgedRetrospective StudiesProstatectomybusiness.industryProstatectomyUrethral sphincterProstatic NeoplasmsRetrospective cohort studyProstheses and ImplantsGeneral MedicineMiddle AgedAdvance slingCombined Modality TherapyTreatment OutcomeChemotherapy AdjuvantImprovement rateHypertensionRadiotherapy AdjuvantImplantmedicine.symptombusinessUrologia Journal
researchProduct

Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.

2007

Drug-eluting stents are increasingly used to reduce in-stent restenosis and adverse cardiac events after percutaneous coronary interventions. However, the race for the ideal drug-eluting stent is still on, with special regard to the best stent-coating system and the most effective and less toxic drug. Fludarabine, a nucleoside analog, has both anti-inflammatory and antiproliferative cellular effects. The aim of the present study was to assess the cellular and molecular effects of fludarabine on vascular smooth muscle cell (VSMC) growth in vitro and in vivo and the feasibility and efficacy of a fludarabine-eluting stent. To study the biomolecular effects of fludarabine on VSMC proliferation…

Malemedicine.medical_specialtyVascular smooth muscleTime FactorsPhysiologyMyocytes Smooth MusclePharmacologyProsthesis DesignTransfectionMuscle Smooth VascularRestenosisIn vivoPhysiology (medical)medicineAnimalsCarotid StenosisRNA AntisensePhosphorylationRats WistarAortaCells CulturedCell ProliferationNeointimal hyperplasiaHyperplasiaDose-Response Relationship Drugbusiness.industryCardiovascular AgentsHyperplasiaJanus Kinase 2medicine.diseaseFludarabineSurgeryRatsDisease Models AnimalSTAT1 Transcription FactorCardiovascular agentSTAT proteinFeasibility StudiesStentsRabbitsCardiology and Cardiovascular MedicinebusinessCarotid Artery InjuriesTunica IntimaAngioplasty BalloonVidarabinemedicine.drug
researchProduct

Visual acuity comparison of 2 models of bifocal aspheric intraocular lenses.

2008

Purpose To compare visual acuity after bilateral implantation of 2 models of multifocal aspheric intraocular lenses (IOLs). Setting Fernandez-Vega Ophthalmological Institute, Oviedo, and University of Valencia, Valencia, Spain. Methods Prospective study of patients who had bilateral implantation of an AcrySof ReSTOR SN6AD3 IOL (Group 1) or an Acri.LISA 366D IOL (Group 2). Six months postoperatively, binocular uncorrected and best corrected distance visual acuity, uncorrected-distance and best distance-corrected near visual acuity, best corrected intermediate visual acuity, and the defocus curve were measured in both IOL groups. Results Group 1 comprised 36 eyes (18 patients) and Group 2, 40…

Malemedicine.medical_specialtyVisual acuityDistance visual acuitygenetic structuresPseudophakiamedicine.medical_treatmentAcrylic ResinsVisual AcuityIntraocular lensProsthesis DesignNear visual acuityFunctional LateralityNear acuityLens Implantation IntraocularOphthalmologymedicineHumansProspective StudiesDioptreAgedLenses IntraocularDepth PerceptionVision BinocularPhacoemulsificationbusiness.industryMiddle Agedeye diseasesSensory SystemsOphthalmologyIntraocular lensesIntermediate visual acuityOptometrySurgeryFemalemedicine.symptombusinessJournal of cataract and refractive surgery
researchProduct